One prescription drug is keeping some addicts from dying. So why isn’t it more widespread? A story of regulation, stigma, and the potentially fatal faith in ...

How pharma greed, government subsidies, and a push to make pain the “fifth vital sign” kicked off a crisis that costs $80 billion a year and has killed ...

We all like to throw around terms that describe human behavior — “bystander apathy” and “steep learning curve” and “hard-wired.” Most of the time, they don’t ...

There is strong evidence that exercise is wildly beneficial. There is even stronger evidence that most people hate to exercise. So if a pill could mimic the ...

In a special holiday episode, Stephen Dubner and Angela Duckworth take turns asking each other questions about charisma, wealth vs. intellect, and (of course) ...

A year ago, nobody was taking Andrew Yang very seriously. Now he is America’s favorite entrepre-nerd, with a candidacy that keeps gaining momentum. This ...

Every year, Americans short the I.R.S. nearly half a trillion dollars. Most ideas to increase compliance are more stick than carrot — scary letters, audits, ...

Innovation experts have long overlooked where a lot of innovation actually happens. The personal computer, the mountain bike, the artificial pancreas — none of ...

There are a lot of barriers to changing your mind: ego, overconfidence, inertia — and cost. Politicians who flip-flop get mocked; family and friends who cross ...

A recent outbreak of illness and death has gotten everyone’s attention — including late-to-the-game regulators. But would a ban on e-cigarettes do more harm ...